Moderna, Inc.

MRNANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.9B

▼ 39.9% YoY

Net Income

-$2.8B

▲ 20.8% YoY

EPS

$-7.26

▲ 21.8% YoY

Cash

$2.6B

▲ 34.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.